Position in CAI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,307,776
+$3,916,534 QoQ
Shares Held
297,855
+282.8% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 246 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Derivatives in CAI
reported options exposure · as of Jun 30, 2026CallValue
$760,914
CallShares
42,700
PutValue
$964,062
PutShares
54,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. CAI ranks #135 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in CAI
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $964,062 | 54,100 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $5,307,776 | 297,855 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $760,914 | 42,700 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $1,391,242 | 77,810 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $266,412 | 14,900 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $665,136 | 37,200 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $1,162,838 | 43,100 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $84,014,532 | 3,113,956 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $644,822 | 23,900 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $408,375 | 13,500 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $692,725 | 22,900 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $9,126,750 | 341,570 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||